Preview

Rational Pharmacotherapy in Cardiology

Advanced search

UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION

https://doi.org/10.20996/1819-6446-2008-4-5-91-105

Full Text:

Abstract

.

About the Authors

K. Thygesen
Department of Medicine and Cardiology, Aarhus University Hospital, Tage Hansens, Gade 2, DK-8000 Aarhus C
Denmark
on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Tel: +45 89 49 76 14; fax: +45 89 49 76 19


J. Alpert
University of Arizona College of Medicine, 1501 N. Campbell Ave, PO Box 245017, Tucson, AZ 85724-5017
United States
on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Department of Medicine, Tel: +1 520 626 6138; fax: +1 520 626 6604


H. White
Green Lane Cardiovascular Service, Auckland City Hospital, Private Bag 92024, 1030 Auckland
New Zealand
on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction, Tel: +64 96309992; fax: +64 96309915


References

1. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined—A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction. Eur Heart J 2000;21:1502–1513; J Am Coll Cardiol 2000;36:959–969.

2. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DG, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy S, Roger VL, Rosamond WD, Shahar E, Sharrett R, Sorlie P, Tunstall-Pedoe H. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. A statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003;108:2543–2549.

3. Jaffe AS, Ravkilde J, Roberts R, Na¨slund U, Apple FS, Galvani M, Katus H. It’s time for a change to a troponin standard. Circulation 2000;102: 1216–1220.

4. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. J Am Coll Cardiol 2006;48:1–11.

5. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99–106.

6. Jaffe AS. Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 2006;48:1763–1764.

7. Panteghini M, Gerhardt W, Apple FS, Dati F, Ravkilde J, Wu AH. Quality specifications for cardiac troponin assays. Clin Chem Lab Med 2001;39:175–179.

8. Apple FS, Jesse RL, Newby LK, Wu AHB, Christenson RH. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes. Circulation 2007;115:e352–e355.

9. Morrow DA, Cannon CP, Jesse RL, Newby LK, Ravkilde J, Storrow AB, Wu AHB, Christenson RH. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers of acute coronary syndromes. Circulation 2007;115:e356–e375.

10. Apple FS, Parvin CA, Buechler KF, Christenson RH, Wu AHB, Jaffe AS. Validation of the 99th percentile cutoff independent of assay imprecision (CV) for cardiac troponin monitoring for ruling out myocardial infarction. Clin Chem 2005;51:2198–2200.

11. Panteghini M, Pagani F, Yeo KT, Apple FS, Christenson RH, Dati F, Mair J, Ravkilde J, Wu AHB on behalf of the Committee on Standardization of Markers of Cardiac Damage of the IFCC. Evaluation of imprecision for cardiac troponin assays at low-range concentrations. Clin Chem 2004; 50:327–332.

12. MacRae AR, Kavsak PA, Lustig V, Bhargava R, Vandersluis R, Palomaki GE, Yerna M-J, Jaffe AS. Assessing the requirement for the six-hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 2006;52:812–818.

13. Apple FS, Murakami MM. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin Chem 2005;51: 460–463.

14. Westgard JO, Klee GG. Quality management. In: Burtis CA, Ashwood ER, Bruns DE, ed. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics, 4th edn). St Louis, MO: Elsevier Saunders; 2006. p498–499.

15. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LE, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC Jr. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction) 2004. J Am Coll Cardiol 2004;44:671–719; Circulation 2004;110:588–636.

16. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, Jones RH, Kereiakes D, Kupersmith J, Levinet TN, Pepine CJ, Schaeffer JW, Smith EA III, Steward DE, Theroux P. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) 2002. J Am Coll Cardiol 2002;40:1366–1374; Circulation 2002;106:1893–1900.

17. Zimetbaum PJ, Josephson ME. Use of the electrocardiogram in acute myocardial infarction. N Engl J Med 2003;348:933–940.

18. Wang K, Asinger RW, Marriott HJ. ST-segment elevation in conditions other than acute myocardial infarction. N Engl J Med 2003;349: 2128– 2135.

19. Holland RP, Brooks H. Precordial and epicardial surface potentials during myocardial ischemia in the pig. A theoretical and experimental analysis of the TQ and ST segments. Circ Res 1975;37:471–480.

20. Richeson JF, Akiyama T, Schenk E. A solid angle analysis of the epicardial ischemic TQ-ST deflection in the pig. A theoretical and experimental study. Circ Res 1978;43:879–888.

21. Ekmekci A, Toyoshima H, Kwoczynski JK, Nagaya T, Prinzmetal M. Angina pectoris V. Giant R wave and receding S wave in myocardial ischemia and certain non-ischemic conditions. Am J Cardiol 1961;7:521– 532.

22. Matetzky S, Barbash GI, Rabinowitz B, Rath S, Zahav YH, Agranat O, Kaplinsky E, Hod H. Q-wave and non Q-wave myocardial infarction after thrombolysis. J Am Coll Card 1995:26:1445–1451.

23. Mcfarlane PW. Age, sex, and the ST amplitude in health and disease. J Electrocardiol 2001;34:S35–S41.

24. Kligfield P, Gettes LS, Bailey JJ, Childers R, Deal BJ, Hancock EW, van Herpen G, Kors JA, Macfarlane P, Mirvis DSc, Pahlm O, Rautaharju P, Wagner GS. Recommendations for the standardization and interpretation of the electrocardiogram. Part I: the electrocardiogram and its technology. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation 2007;115:1306–1324; J Am Coll Cardiol 2007;49:1109–1127; Heart Rhythm 2007;4:394– 412.

25. Zimetbaum PJ, Krishnan S, Gold A, Carrozza JP II, Josephson ME. Usefulness of ST-segment elevation in lead III exceeding that of lead II for identifying the location of the totally occluded coronary artery in inferior wall myocardial infarction. Am J Cardiol 1998;81:918–919.

26. Engelen DJ, Gorgels AP, Cheriex EC, De Muinck ED, Ophuis AJO, Dassen WR, Vainer J, van Ommen VG, Wellens HJ. Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction. J Am Coll Cardiol 1999;34:389–395.

27. Matetzky S, Freimark D, Feinberg MS, Novikov I, Rath S, Rabinowitz B, Kaplinsky E, Hod H. Acute myocardial infarction with isolated ST segment elevation in posterior chest leads V7–V9. Hidden ST-segment elevations revealing acute posterior infarction. J Am Coll Cardiol 1999; 34:748–753.

28. Agarwal JB, Khaw K, Aurignac F, LoCurto A. Importance of posterior chest leads in patients with suspected myocardial infarction, but nondiagnostic 12-lead electrocardiogram. Am J Cardiol 1999;83:323–326.

29. Baye´s de Luna A, Wagner G, Birnbaum Y, Nikus K, Fiol M, Gorgels A, Cinca J, Clemmensen PM, Pahlm O, Sclarowsky S, Stern S, Wellens H. A new terminology for the left ventricular walls and for the location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging. A statement for healthcare professionals from a Committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circulation 2006;114: 1755–1760.

30. Lopez-Sendon J, Coma-Canella I, Alcasena S, Seoane J, Gamallo C. Electrocardiographic findings in acute right ventricular infarction: sensitivity and specificity of electrocardiographic alterations in right precordial leads V4R, V3R, V1, V2 and V3. J Am Coll Cardiol 1985;6:1273– 1279.

31. Sgarbossa EB, Pinsky SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, Califf RM, Wagner GS. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle branch block. N Engl J Med 1996;334:481–487.

32. Wong C-K, French JK, Aylward PEG, Stewart RAH, Gao W, Armstrong PW, Van De Werf FJJ, Simes RJ, Raffel OC, Granger CB, Califf RM, White HD. Patients with prolonged ischemic chest pain and presumednew left bundle branch block have heterogenous outcomes depending on the presence of ST-segment changes. J Am Coll Cardiol 2005;46: 29–38.

33. Savage RM, Wagner GS, Ideker RE, Podolsky SA, Hackel DB. Correlation of postmortem anatomic findings with electrocardiographic changes in patients with myocardial infarction: retrospective study of patients with typical anterior and posterior infarcts. Circulation 1977;55: 279–285.

34. Horan LG, Flowers NC, Johnson JC. Significance of the diagnostic Q wave of myocardial infarction. Circulation 1971;43:428–436.2536 K. Thygesen et al.

35. Pahlm US, Chaitman BR, Rautaharju PM, Selvester RH, Wagner GS. Comparison of the various electrocardiographic scoring codes for estimating anatomically documented sizes of single and multiple infarcts of the left ventricle. Am J Cardiol 1998;81:809–815.

36. Rautaharju PM, Park LP, Chaitman BR, Rautaharju F, Zhang Z-M. The Novacode criteria for classification of ECG abnormalities and their clinically significant progression and regression. J Electrocardiol 1998;31: 157–187.

37. Porela P, Helenius H, Pulkki K, Voipio-Pulkki LM. Epidemiological classification of acute myocardial infarction: time for a change? Eur Heart J 1999;20:1459–1464.

38. Yokoyama Y, Chaitman BR, Hardison RM, Guo P, Krone R, Stocke K, Gussak I, Attubato MJ, Rautaharju PM, Sopko G, Detre KM. Association between new ECG abnormalities after coronary revascularization and five year cardiac mortality in BARI randomized and registry patients. Am J Cardiol 2000;86:819–824.

39. Korosoglou G, Labadze N, Hansen A, Selter C, Giannitsis E, Katus H, Kuecherer H. Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. Am J Cardiol 2004;94:1225–1231.

40. Dakik HA, Howell JF, Lawrie GM, Espada R, Weilbaecher DG, He Z-X, Mahmarian JJ, Verani MS. Assessment of myocardial viability with 99mTcsestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997;96:2892–2898.

41. Medrano R, Lowry RW, Young JB, Weilbaecher DG, Michael LH, Afridi I, He Z-X, Mahmarian JJ, Verani MS. Assessment of myocardial viability with 99mTc-sestamibi in patients undergoing cardiac transplantation: a scintigraphic/pathological study. Circulation 1996;94:1010–1017.

42. Klein C, Nekolla SG, Bengel FM, Momose M, Sammer A, Haas F, Schnackenburg B, Delius W, Mudra H, Wolfram D, Schwaiger M. Assessment of myocardial viability with contrast- enhanced magnetic resonance imaging: comparison with positron emission tomography. Circulation 2002;105:162–167.

43. Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, Klocke FJ, Bonow RO, Kim RJ, Judd RM. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet 2003;361:374–379.

44. Wackers FJ, Berger HJ, Johnstone DE, Goldman L, Reduto LA, Langou RA, Gottschalk A, Zaret BL. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability. Am J Cardiol 1979;43:1159–1166.

45. Mahmarian JJ, Moye L, Verani MS, Eaton T, Francis M, Pratt CM. Criteria for the accurate interpretation of changes in left ventricular ejection fraction and cardiac volumes as assessed by rest and exercise gated radionuclide angiography. J Am Coll Cardiol 1991;18:112–119.

46. Lima JAC. Myocardial viability assessment by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol 2003;42:902–904.

47. Isbell DC, Kramer CM. Cardiovascular magnetic resonance: structure, function, perfusion, and viability. J Nucl Cardiol 2005;12:324–336.

48. Gosalia A, Haramati LB, Sheth MP, Spindola-Franco H. CT detection of acute myocardial infarction. Am J Roentgenol 2004;182:1563– 1566.

49. Mahnken AH, Koos R, Katoh M, Wildberger JE, Spuentrup E, Buecker A, Gu¨nther RW, Ku¨hl HP. Assessment of myocardial viability in reperfused acute myocardial infarction using 16-slice computed tomography in comparison to magnetic resonance imaging. J Am Coll Cardiol 2005;45:2042–2047.

50. Buda AJ. The role of echocardiography in the evaluation of mechanical complications of acute myocardial infarction. Circulation 1991; 84(Suppl I): I-109–I-121.

51. Peels C, Visser CA, Kupper AJ, Visser FC, Roos JP. Usefulness of twodimensional echocardiography for immediate detection of myocardial ischemia in the emergency room. Am J Cardiol 1990;65:687–691.

52. Sabia P, Abbott RD, Afrookteh A, Keller MW, Touchstone DA, Kaul S. Importance to two-dimensional echocardiographic assessment of left ventricular systolic function in patients presenting to the emergency room with cardiac-related symptoms. Circulation 1991;84:1615–1624.

53. Saeian K, Rhyne TL, Sagar KB. Ultrasonic tissue characterization for diagnosis of acute myocardial infarction in the coronary care unit. Am J Cardiol 1994;74:1211–1215.

54. Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS, Ornato JP. Comprehensive strategy for the evaluation and triage of the chest pain patients. Ann Emerg Med 1997;29:116–125.

55. Udelson JE, Beshansky JR, Ballin DS, Feldman JA, Griffith JL, Handler J, Heller GV, Hendel RC, Pope JH, Ruthazer R, Spiegler EJ, Woolard RH, Selker HP. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA 2002;288:2693–2700.

56. Stowers SA, Eisenstein EL, Wackers FJT, Berman DS, Blackshear JL, Jones AD Jr, Szymanski TJ Jr, Lam LC, Simons TA, Natale D, Paige KA, Wagner GS. An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but non-diagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med 2000;35:17– 25.

57. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen E-L, Simonetti O, Bundy J, Finn JP, Klocke FJ, Judd RM. Relationship of MRI delayed contrast enhancement to irreversible necrosis, infarct age, and contractile function. Circulation 1999;100:1992–2002.

58. Harris BM, Nageh T, Marsden JT, Thomas MR, Sherwood RA. Comparison of cardiac troponin T and I and CK-MB for the detection of minor myocardial damage during interventional cardiac procedures. Ann Clin Biochem 2000;37:764–769.

59. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, Lee-Lewandrowski E. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol 2002;39:1518–1523.

60. Holmvang L, Jurlander B, Rasmussen C, Thiis JJ, Grande P, Clemmensen P. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest 2002;121:103–111.

61. Miller WL, Garratt KN, Burritt MF, Reeder GS, Jaffe AS. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest 2004;25:275–280.

62. Anderson KM, Califf RM, Stone GW, Neumann F-J, Montalescot G, Miller DP, Ferguson JJ III, Willerson JT, Weisman HF, Topol EJ. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J Am Coll Cardiol 2001;37:2059–2065.

63. Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, Simoons ML. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation 2002;105:554–556.

64. Saadeddin SM, Habbab MA, Sobki SH, Ferns GA. Minor myocardial injury after elective uncomplicated successful PTCA with or without stenting: detection by cardiac troponins. Catheter Cardiovasc Intervent 2001;53:188–192.

65. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, Judd RM, Kim RJ. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 2001;103:2780–2783.

66. Ricciardi MJ, Davidson CJ, Gubermikoff G, Beohar N, Eckman LJ, Parker MA, Bonow RO. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003;145:522–528.

67. Herrman J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 2005;26:2493–2519.

68. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation 2005;111:1027–1032.

69. Benoit MO, Paris M, Silleran J, Fiemeyer A, Moatti N. Cardiac troponin I: its contribution to the diagnosis of perioperative myocardial infarction and various complications of cardiac surgery. Crit Care Med 2001;29: 1880–1886.

70. Kovacevic R, Majkic-Singh N, Ignjatovic S, Otasevic P, Obrenovic R, Paris M, Vilotijevic B, Guermonprez JL. Troponin T levels in detection of perioperative myocardial infarction after coronary artery bypass surgery. Clin Lab 2004;50:437–445.

71. Noora J, Ricci C, Hastings D, Hills S, Cybulsky I. Determination of troponin I release after CABG surgery. J Card Surg 2005;20:129–135.

72. Selvanayagam JB, Pigott D, Balacumaraswami L, Petersen SE, Neubauer S, Taggart DP. Relationship of irreversible myocardial injury to troponin I and creatine kinase-MB elevation after coronary artery bypass surgery: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol 2005;45:629–631.

73. Costa MA, Carere RG, Lichtenstein SV, Foley DP, de Valk V, Lindenboom W, Roose PCH, van Geldorp TR, Macaya C, Castanon JL, Ferna´ndezAvile`z F, Gonza´les JH, Heyer G, Unger F, Serruys PW. Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with Universal definition of myocardial infarction 2537 bypass surgery in the arterial revascularization therapies study (ARTS). Circulation 2001;104:2689–2693

74. Ioannidis JPA, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol 2003;42:1406–1411.

75. Croal BL, Hillis GS, Gibson PH, Fazal MT, El-Shafei H, Gibson G, Jeffrey RR, Buchan KG, West D, Cuthbertson BH. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 2006;114:1468–1475.

76. Gustavsson CG, Hansen O, Frennby B. Troponin must be measured before and after PCI to diagnose procedure-related myocardial injury. Scand Cardiovasc J 2004;38:75–79.

77. Miller WL, Garratt KN, Burrit MF, Lennon RJ, Reeder GS, Jaffe AS. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J 2006;27:1061–1069.

78. Klatte K, Chaitman BR, Theroux P, Gavard JA, Stocke K, Boyce S, Bartels C, Keller B, Jessel A. Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release. J Am Coll Cardiol 2001;38:1070–1077.

79. Brener SJ, Lytle BW, Schneider JP, Ellis SG, Topol EJ. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality. J Am Coll Cardiol 2002;40:1961–1967.

80. Chew DP, Bhatt DL, Lincoff AM, Wolski K, Topol EJ. Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk. Heart 2006;92: 945–950.

81. Panteghini M, Cuccia C, Bonetti G, Giubbini R, Pagani F, Bonini E. Singlepoint cardiac troponin T at coronary care unit discharge after myocardial infarction correlates with infarct size and ejection fraction. Clin Chem 2002;48:1432–1436.

82. Licka M, Zimmermann R, Zehelein J, Dengler TJ, Katus HA, Kubler W. Troponin T concentrations 72 h after myocardial infarction as a serological estimate of infarct size. Heart 2002;87:520–524.

83. Gallegos RP, Swingen C, Xu XJ, Wang XM, Bianco R, Jerosch-Herold M, Bolman RM III. Infarct extent by MRI correlates with peak serum troponin level in the canine model. J Surg Res 2004;120: 266–271.

84. Meier MA, Al-Badr WH, Cooper JV, Kline-Rogers EM, Smith DE, Eagle KA, Mehta RH. The new definition of myocardial infarction: diagnostic and prognostic implications in patients with acute coronary syndromes. Arch Intern Med 2002;162:1585–1589.

85. Kontos MC, Fritz LM, Anderson FP, Tatum JL, Ornato JP, Jesse RL. Impact of the troponin standard on the prevalence of acute myocardial infarction. Am Heart J 2003;146:446–452.

86. Salomaa V, Koukkunen H, Ketonen M, Immonen-Ra¨iha¨ P, Ka¨rja¨-Koskenkari P, Mustonen J, Lehto S, Torppa J, Lehtonen A, Tuomilehto J, Kesa¨niemi YA, Pyo¨ra¨la¨ K. A new definition for myocardial infarction: what difference does it make? Eur Heart J 2005;27:1719–1725.

87. Roger VL, Killian JM, Weston SA, Jaffe AS, Kors J, Santrach PJ, TunstallPedoe H, Jacobsen SJ. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation 2006;114:790–797.


For citation:


Thygesen K., Alpert J., White H. UNIVERSAL DEFINITION OF MYOCARDIAL INFARCTION. Rational Pharmacotherapy in Cardiology. 2008;4(5):91-105. (In Russ.) https://doi.org/10.20996/1819-6446-2008-4-5-91-105

Views: 602


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)